In Brief
A functional reciprocal interaction between dopamine and acetylcholine is critical to contain and regulate acetylcholine signaling in the striatum. Genetic deletion of D2 receptors on striatal cholinergic interneurons reduced the in vitro pause response, with consequences on striatal medium spiny neurons and motor activity. We reveal that acetylcholine operates as a trigger of catalepsy generated by typical antipsychotics such as haloperidol.
INTRODUCTION
Aberrant dopaminergic control of striatal circuits contributes to human neurological and psychiatric disorders (Crittenden and Graybiel, 2011) . In the striatum, medium spiny neurons (MSNs) are the most abundant neurons and the only output of this structure. MSNs are thus critical elements in striatum-regulated functions such as the control of movement and motivation. Neuronal networks formed by extra-striatal and intra-striatal inputs finely regulate MSN activity (Gittis and Kreitzer, 2012) . Dopamine (DA) is a major modulator of MSN activity. Indeed, loss of DA neurons in Parkinson's disease impairs voluntary movements and other DA-dependent functions (Gittis and Kreitzer, 2012; Surmeier, 2013) . However, DA regulation of striatal neurons is not restricted to MSNs but also extends to striatal cholinergic interneurons (ChIs) that, despite their low number, appear to regulate striatal microcircuits (Aosaki et al., 2010; Nelson et al., 2014; Witten et al., 2010) .
ChIs, also known as tonically active neurons (Aosaki et al., 1994a; Apicella, 2002) , integrate excitatory inputs from the thalamus and cortex with inputs from DA and GABA neurons, leading to regulation of MSN outputs (Chuhma et al., 2014; Surmeier and Graybiel, 2012) . Previous studies have revealed the presence of a reciprocal relationship between DA neurons and ChIs. Acetylcholine (ACh) stimulates dopaminergic neurons activity and the release of DA and GABA (Cachope et al., 2012; Nelson et al., 2014; Threlfell et al., 2012) ; in return, DA inhibits or stimulates ChI activity and ACh release, depending on whether it acts through D2 receptors (D2R) (Straub et al., 2014) or D5R (Aosaki et al., 2010; Centonze et al., 2003; Lester et al., 2010) . The synergism between DA and ACh has important consequences for the activity of MSNs, which compose the direct and indirect pathways (Gerfen and Surmeier, 2011) . Importantly, the activity of MSNs is modulated by muscarinic receptors (Threlfell et al., 2010; Threlfell and Cragg, 2011) . These findings suggest the presence of a tight DA-regulated interplay between MSN and ChI activity.
D2Rs are central regulators of the DA/ACh interaction, since both DAergic neurons and ChIs express these receptors. D2R activation inhibits neuronal activity and the release of DA (Anzalone et al., 2012) and ACh (DeBoer and Abercrombie, 1996) . Interestingly, DA bursts have been shown to induce pauses in the tonic activity of striatal ChIs and to trigger a transient suppression of cortical inputs on the MSNs within the indirect pathway (Ding et al., 2010; Shen et al., 2007; Thorn and Graybiel, 2010) . This class of MSNs (Gerfen and Surmeier, 2011) expresses D2R (Delle Donne et al., 1997) whose signaling modulates the striato-thalamiccortical circuit (Surmeier et al., 2009; Tozzi et al., 2011) . Importantly, antipsychotics used in the treatment of schizophrenia and other psychiatric disorders block D2R signaling. In humans, blockade of D2Rs with the typical antipsychotic haloperidol has debilitating side effects known as extrapyramidal symptoms, which include dystonia, parkinsonism, and tardive dyskinesia. In rodents, haloperidol induces catalepsy, the inability to initiate voluntary movements. To date, the mechanisms underlying the side effects of antipsychotics are not fully understood.
Given the complex interplay between neuronal types and DA signaling together with the heterogeneous D2R distribution, the functional contribution of D2R in specific striatal neurons has been difficult to address, especially in the very sparse ChIs (Tepper and Bolam, 2004) . To solve this question of both conceptual and biomedical importance, we have generated mice with celltype-specific ablation of D2R in ChIs (hereafter named ChI-D2RKO mice). Importantly, the ChIs of ChI-D2RKO mice show significantly shorter pauses in firing after intrastriatal stimulation, corroborating a critical role of D2R signaling in generating the pause in vitro. Strikingly, the catalepsy induced by haloperidol is suppressed in ChI-D2RKO mice. These results underline the importance of D2R signaling in ChIs in the control of motor function and will be valuable toward the development of alternative pharmacological strategies.
RESULTS

Ablation of D2Rs from ChIs
D2Rs are expressed on many striatal cell types, as well as on the axon terminals of many striatal inputs (De Mei et al., 2009 ). Pharmacological tools cannot target D2R in specific cell types in vivo, preventing the elucidation of the role of D2R signaling in ChIs. We sought to address this issue of fundamental biomedical importance by generating ChI-specific D2RKO (ChI-D2RKO) mice and analyzing how their ablation would influence behavioral and cellular parameters. D2R floxed mice (Anzalone et al., 2012) were crossed with heterozygous transgenic mice expressing Cre recombinase under the control of the choline acetyl transferase (ChAT) promoter (Gong et al., 2003) (Figure S1A ). Southern blot analyses confirmed the presence of drd2 floxed alleles as well as of cre recombinase in the genome of ChI-D2RKO mice ( Figure S1B ). ChI-D2RKO mice have normal weight, size, and fertility as compared to wild-type (WT) littermates. Since ChIs constitute 1%-2% of total striatal cell population (Tepper and Bolam, 2004) , we assessed the full deletion of D2R in these interneurons by fluorescence-activated cell sorting (FACS) experiments using ChAT antibodies and DAPI as marker of nuclei ( Figure 1A ) followed by qRT-PCR of RNAs prepared from sorted ChATpositive and -negative neurons from animals of both genotypes. These experiments confirmed the absence of D2R-specific transcripts only in the ChIs of ChI-D2RKO as compared to WT mice (p < 0.05 Figure 1B ), while in ChAT-negative neurons, both genotypes showed similar levels of D2R expression (p > 0.05).
ACh is involved in the control of DA release from the dopaminergic terminals via activation of nicotinic (Rice et al., 2011) and muscarinic receptors (Foster et al., 2014) ; abnormal ChI function in ChI-D2RKO mice might alter evoked DA release. We thus compared the evoked DA overflow in the dorsal striatum by performing cyclic voltammetry (CV) in WT and ChI-D2RKO brain slices. CV data analysis revealed that a similar level of DA overflow was evoked in both genotypes in response to single pulse electrical stimulation (n = 30/group; p = 0.35; Figure 1C , left panel); instead, 20 Hz pulse trains elicited a significant increase of DA overflow in ChI-D2RKO as compared to WT mice (p = 0.02; Figure 1C, right panel) . We then tested D2 autoreceptor-mediated inhibition of DA overflow in ChI-D2RKO mice. When incubated with 0.5 mM of the D2R agonist quinpirole, ChI-D2RKO slices displayed quinpirole-mediated reduction in DA overflow, an effect still present but to a lesser extent in WT littermates (p < 0.0001; Figure 1D ). Thus, absence of control of D2R on ChIs affects DA release. Figure S1 .
Reduced ChI ''Pause'' in the Absence of D2R To determine whether deletion of D2Rs from ChIs might generate changes in their intrinsic or synaptic properties, we performed both cell-attached and whole-cell patch-clamp recordings of ChI in coronal brain slices from adult ChI-D2RKO and WT littermates (Figure 2A) . At 33 C, ChIs of both genotypes fired spontaneously in cell-attached mode ( Figure 2B ), as previously reported in rodents (Bennett and Wilson, 1999) . The observed rates were not significantly different (p = 0.69; Figure 2B , right panel). ChIs from both genotypes showed typical intrinsic properties in whole-cell current-clamp mode ( Figure 2C ), which did not differ between WT and ChI-D2RKO slices (Table S1 ), suggesting that the ionic conductances responsible for tonic firing and responses to hyperpolarizing and depolarizing stimuli are not grossly disrupted in ChI-D2RKO mice. Several studies have described a ''pause'' in the firing of ChIs in vivo in response to salient or reward-predictive stimuli (Aosaki et al., 1994b) . The synaptic and cellular mechanisms are not entirely understood, although DA is involved (Aosaki et al., 1994b; Straub et al., 2014) . To examine whether the pause may be disrupted in ChI-D2RKO mice, we modified a previously published in vitro protocol for eliciting a pause in the spontaneous firing of ChIs (Ding et al., 2010) , using intrastriatal rather than thalamic stimulation. This 50 Hz, 5-pulse protocol is expected to activate both cortical and thalamic afferents to ChIs, as well as local DA inputs, and elicited an immediate excitatory response followed by a pause response in WT ChIs ( Figure 2D , left panel). We quantified the ChI pause in two ways: (1) the difference between the observed first post-stimulation interspike interval (ISI) and the expected ISI based on the baseline firing rate and (2) the ratio of the observed ISI and the expected ISI. In WT slices, the pause was 278 ± 105 ms in duration (n = 15 neurons), and the ISI ratio was 1.72 ± 0.38 (n = 15 neurons). These values are somewhat lower than previously observed (Ding et al., 2010) and may be related to the use of intrastriatal rather than thalamic stimulation, as well as the use of a train of five rather than ten stimuli. Prior work has suggested that the pause in vivo and in vitro is dopamine mediated, but a pause has also been observed in response to stimulation of midbrain GABAergic neurons (Brown et al., 2012) . To determine whether the in vitro pause response we elicited was dopamine dependent, GABA dependent, or both, we applied the GABA receptor antagonist picrotoxin and the D2R antagonist sulpiride sequentially to WT neurons. Only the latter caused a marked reduction in the duration of the pause (Figure S2 ), suggesting that in our recordings, DA was the major contributor. In ChI-D2RKO mice, the pause response to such stimulation was also markedly reduced as compared to WT mice ( Figure 2D , right panel), measuring 25 ± 38 ms ( Figure 2E ; n = 24; p = 0.013 in comparison to WT) with an ISI ratio of 1.13 ± 0.05 ( Figure 2F ; n = 24; p = 0.012 in comparison to WT). These findings demonstrate that a dopamine-dependent in vitro pause response, which bears some similarities to that seen in vivo in response to reward or reward-predictive cues, is markedly reduced in ChI-D2RKO mice.
D2R Signaling in ChIs Modulates Motor Behavior
Next, we assessed the impact of D2R removal from ChIs on motor activity under basal conditions. Forward locomotion was recorded in ChI-D2RKO mice and WT littermates during the light/ dark cycle using an actimetric rack ( Figure S3A ) or during 1 hr in a novel home cage (NHC) ( Figure S3B ). Both genotypes had similar locomotor (NHC: n = 14/genotype; p > 0.05; Actimetric: n = 8/genotype; p > 0.05) and rearing activity in the NHC (n = 11; p > 0.05, Figure S3B ). These results indicate that loss of D2R on ChIs does not lead to major motor deficits in ChI-D2RKO mice analyzed in basic conditions. DA acting through either D2R (inhibitory) or D5R (stimulatory) modulates the activity of ChIs; at the same time, DA excites MSNs of the direct pathway through D1R signaling while inhibiting MSNs of the indirect pathway through D2R (Gerfen and Surmeier, 2011) . ACh signaling has the opposite effect than DA on the direct and indirect pathways (Aosaki et al., 2010; Shen et al., 2008; Surmeier, 2013) . In addition, ACh stimulates DA release from dopaminergic neurons (Cachope et al., 2012; Threlfell et al., 2012) . To test the hypothesis that ChIs contribute to the regulation of motor activity upon DA stimulation, we analyzed ChI-D2RKO motor behavior after pharmacological challenge using agonists and antagonists for both D1Rs and D2Rs.
In the mouse, quinpirole, a D2R agonist, depresses motor activity (Usiello et al., 2000) . This effect depends on the presynaptic inhibition of DA release (Usiello et al., 2000) but also the heterosynaptic inhibition of the release of other neurotransmitters from striatal (ChI, MSN) as well as extrinsic neurons (Anzalone et al., 2012; Bamford et al., 2004; DeBoer and Abercrombie, 1996) . Systemic administration of quinpirole dose-dependently decreased motor activity in mice of both genotypes ( Figure 3A ). However, quinpirole more efficiently reduced motor activity in ChI-D2RKO mice than in WT siblings. This difference hints to a more efficient quinpirole-mediated inhibition of DA levels in ChI-D2RKO mice particularly evident at the lowest concentration used. It has been shown that ACh regulates DA release through stimulation of nicotinic receptors on DA terminals (Rice et al., 2011) . The knockout of D2Rs in ChIs by preventing the DA-mediated inhibition of ACh release might result into desensitization of nicotinic receptors on DA neurons with a consequent decrease of DA levels (Threlfell et al., 2010) .
Stimulation of D1-like receptors was achieved using SKF 81297. This compound stimulates striatal D1Rs expressed by MSNs and D5Rs by ChIs (Aosaki et al., 2010) and increases motor activity (Usiello et al., 2000) . SKF81297 administration, analyzed during 1 hr in NHC, dose-dependently induced forward locomotion in mice of both genotypes ( Figure 3B ). Nevertheless, in response to SKF 81297, there was a clear trend toward a lower induction of motor activity in ChI-D2RKO as compared to WT mice. This result suggests that SKF81297 less efficiently activate D1R signaling on the MSNs of ChI-D2RKO mice. Importantly, SKF81297 also stimulates D1-like receptors (D5R) on ChIs inducing ACh release (Abercrombie and DeBoer, 1997; DeBoer and Abercrombie, 1996) . Thus, a reasonable explanation for these results is that loss of the D2R-mediated inhibition of ACh in ChI-D2RKO mice further promotes SKF81297-mediated ACh release. Stimulation of the inhibitory M4 receptors on D1R + -MSNs counterbalances the direct activation by SKF 81297 of D1Rs on these same neurons inhibiting their activity and consequently locomotion. In support of these results, analyses of the D1R-and cAMP-dependent phosphorylation of GluR1 (Ser 845 residue) (Snyder et al., 2000) by SKF 81297 paralleled behavioral data showing lower induction of GluR1 phosphorylation in ChI-D2RKO striatal extracts as compared to WT ( Figure S3C) . Altogether, the behavioral responses of ChI-D2RKO mice to D1-and D2-like agonists suggest the presence of finely tuned control mechanisms of motor activity involving the dopaminergic regulation of ChIs.
D2R Signaling in ChIs Partition Motor and Cataleptic Responses
Blockade of either D1-like or D2-like receptors greatly reduces forward locomotion and induces catalepsy (Usiello et al., 2000) . SCH23390, a D1-like antagonist, and haloperidol, a D2-like antagonist, dose-dependently reduced forward locomotion in mice of both genotypes ( Figures 3C, 3D , and S3D).
Interestingly, both SCH23390-and haloperidol-induced catalepsy as measured with the bar test were markedly different between genotypes. SCH 23390-induced catalepsy was much less prominent in ChI-D2RKO than in WT mice (p < 0.0001; Figure 3E) . Even more surprising, while haloperidol produces catalepsy in control mice, it does not in ChI-D2RKO mice at all doses tested (p < 0.0001; Figure 3F ) as well as at different time points after administration (p < 0.01; Figure S3E ). These results indicate that catalepsy arises from the acute blockade of DA receptors not only on MSNs but more importantly on ChIs. Interestingly, D2Rs control ACh release (Abercrombie and DeBoer, 1997) and scopolamine, a non-selective muscarinic antagonist, has been reported to attenuate haloperidolinduced catalepsy (Fink-Jensen et al., 2011) . Thus, our experiments suggest that the D2R-mediated control of striatal ChI physiology critically modulates catalepsy. In agreement, scopolamine reversed the effect of haloperidol on catalepsy in WT mice ( Figure S3F ), while, as expected, it has no effect on ChI-D2RKO mice.
Haloperidol-Induced Cellular Responses Are Blunted in ChI-D2RKO Mice We next explored the intracellular effects of loss of D2R signaling in ChI-D2RKO mice. We used a marker of intracellular signaling activation, the phosphorylation of the ribosomal protein S6 (rpS6) on Ser 235/236 and Ser 240/244 residues (Knight et al., 2012) . Phosphorylation (P) of these residues in the striatum in response to haloperidol has been linked to the activation of the cAMP (Ser 235/236 ) (Valjent et al., 2011) and mTorc 1 (Ser 240/244 ) signaling pathways (Bonito-Oliva et al., 2013) . Furthermore, phosphorylation of Ser 240/244 has been proven to reflect activation of striatal ChIs (Bertran-Gonzalez et al., 2012) . We used antibodies directed against P-rpS6-Ser 240/244 together with choline acetyltransferase (ChAT) to investigate activation of intracellular signaling in ChIs in response to haloperidol in the dorsolateral striatum (DLS) (Gerfen, 1992 ) of WT and ChI-D2RKO mice 1 hr after haloperidol administration ( Figure 4A ). Saline treatment did not alter the percentage of rpS6-Ser 240/244 phosphorylation in ChIs or of fluorescence intensity/cell in the DLS of WT and ChI-D2RKO sections ( Figures 4A and 4B ). In agreement with previous reports, haloperidol administration induced P-rpS6-Ser 240/244 in the vast majority of ChIs as well as the fluorescence intensity/cell in the WT DLS ( Figures 4A and 4B, left and right) . Strikingly, the induction of rpS6-Ser 240/244 phosphorylation in response to haloperidol was completely abolished in the ChIs of ChI-D2RKOs (p < 0.0001; Figures 4A and 4B, left and right) .
In striatal D2R + -MSNs, haloperidol induces the phosphorylation of rpS6 on Ser 235/236 (Valjent et al., 2011) . To explore the possibility that dampening of rpS6 phosphorylation after haloperidol in ChI-D2RKO ChIs might also indirectly affect signaling to rpS6 in D2R + -MSNs, we performed double immunofluorescence analyses using antibodies specific for P-rpS6-Ser Figures 4C and 4D ). Interestingly, in ChI-D2RKO striata the number of P-rpS6-positive D2R + -MSNs was less than half that of WT mice (p < 0.0001; Figure 4D , left and right), and the fluorescence intensity/cell did not increase with respect to saline treated mice, although it was sensibly higher in saline conditions in ChI-D2RKO as compared to WT D2R + -MSNs (p < 0.0001; Figure 4D) . These results show that a smaller population of D2R + -MSNs responds to haloperidol in ChI-D2RKO as compared to WT mice and that these events correlate with the dampened signaling to rpS6-Ser 240/244 in ChIs.
ACh Signaling Mediates the Cataleptic Effect of Haloperidol
ChIs of the DLS express M2 and M4 muscarinic autoreceptors that inhibit ACh release (Threlfell et al., 2010) . In addition, ACh release is also negatively regulated by DA through activation of D2Rs. Absence of D2R in the ChIs removes the dopaminergic inhibition over ACh release, which in specific conditions (i.e., haloperidol treatment) might lead to a sustained ACh-mediated activation of muscarinic autoreceptors and consequent reduction of ACh release. Thus, we hypothesized that absence of catalepsy in ChI-D2RKO mice might be explained by a reduced cholinergic signaling in the striatum. To test this hypothesis, we blocked ACh degradation using donepezil, an acetylcholinesterase inhibitor, which increases striatal ACh levels (Karvat and Kimchi, 2014) , and tested the behavioral and cellular effects on haloperidol-treated ChI-D2RKO and WT littermates. Importantly, no changes in the expression of M2, M4, or M1 muscarinic receptors were detected between WT and ChI-D2RKO mice ( Figure S4A ). Mice were given combined treatments with donepezil (0.3 or 1mg/kg) or saline 15 min prior to haloperidol (1mg/kg) or saline administration. Locomotion as well as catalepsy were measured 1 hr after the last injection (Figures 5A and 5B). Single haloperidol or donepezil administration significantly affected motor activity in WT and ChI-D2RKO mice (treatment: p < 0.0001; Figure 5A ); when combined, the two drugs did not reduce further motor activity as compared to haloperidol in both genotypes. Figure 5B ). Importantly, however, donepezil administration prior to haloperidol dose-dependently restored catalepsy (p < 0.0001, both doses versus saline) in ChI-D2RKO mice reaching WT levels at the highest dose ( Figure 5B ). Donepezil did not increase haloperidolinduced catalepsy in WT mice ( Figure 5B ). These findings point to ACh signaling being involved in the side effects of haloperidol through blockade of D2Rs located on ChIs.
Donepezil by itself did not induce catalepsy (
To determine whether the restoration of haloperidol-induced catalepsy in donepezil-treated ChI-D2RKO mice was accompanied by normalization of haloperidol-induced cellular responses, we assessed the induction of rpS6 phosphorylation in simple or combined treatments. Interestingly, donepezil by itself induced rpS6-Ser 240/244 phosphorylation in a similar percentage of ChIs (p < 0.05) and fluorescence intensity/cell (p < 0.0001) in both genotypes ( Figure 5C ). Combined donepezil and haloperidol treatments did not further increase the percentage or intensity/cell as compared to donepezil alone ( Figure 5C ). These results support our hypothesis of a diminished ACh level in ChI-D2RKO. Importantly, at the intracellular level donepezil in WT and ChI-D2RKO mice induced rpS6-Ser 235/236 phosphorylation in a similar number of D2R + -MSNs in both genotypes (p < 0.05; Figure 5D , left). In addition, combined with haloperidol, donepezil had a cumulative effect on both the number of induced cells (p < 0.05-0.01; Figure 5D , left) and on fluorescence intensity/ cell in both genotypes (p < 0.0001, Figure 5D , right). These results indicate that ACh is directly involved in the stimulation of ChIs and D2R + -MSNs signaling that leads to rpS6 phosphorylation and suggest that catalepsy is induced by the increased release of ACh from ChIs and activation of muscarinic receptors on MSNs in the presence of a D2R antagonist. In line with these findings, scopolamine (1 mg/kg) decreased haloperidol-induced (1 mg/kg) phosphorylation of rpS6-Ser 240/244 in ChIs ( Figures  S4B and S4C) Figure S4C ).
Typical versus Atypical Antipsychotics
Haloperidol, the prototype of typical antipsychotics, induces catalepsy, while atypical antipsychotics such as clozapine do not (Vauquelin et al., 2012) . Clozapine has partial agonist (M2/ M4) as well as antagonist (M1) effects on muscarinic receptors (Michal et al., 1999; Seeman, 2014; Zeng et al., 1997) . We hypothesized that absence of clozapine-induced catalepsy might depend on the pharmacological properties of this compound for muscarinic receptors. In this case scenario, we would expect clozapine to have similar effects on rpS6 phosphorylation in WT and ChI-D2RKO mice. We first assessed that clozapine at 1 and 3 mg/kg was equally able to reduce horizontal motor activity in both WT and ChI-D2RKO mice ( Figure S5 ). Interestingly, the phosphorylation pattern of rpS6 in ChI-D2RKO slices in response to clozapine administration ( Figures 6A-6D ) was These results are consistent with our hypothesis that the absence of clozapine-induced catalepsy is due to its heterogeneous affinity for multiple receptors including muscarinic receptors (Michal et al., 1999; Zeng et al., 1997; Seeman, 2014) . Indeed, clozapine was able to reduce the extent of rpS6-Ser 235/236 phosphorylation induced by donepezil in D2R + -MSNs (p < 0.05; Figure 6F , left and right), likely antagonizing M1 receptors on these cells (Seeman, 2014) , but not on ChIs (p < 0.05; Figure 6E left and right) through the partial agonist activity. These results suggest that typical antipsychotics induce catalepsy through selective ACh stimulation of D2R + -MSNs. In support of this conclusion, we performed experiments in which M1 muscarinic receptors were blocked by the specific antagonist N-[3-oxo-3-[4-(4-pyridinyl)-1-piperazinyl]propyl]-2,1,3-benzothiadiazole-4-sulfonamide (VU0255035) (Maltese et al., 2014; Xiang et al., 2012) . Administration of VU0255035 (30 and 60 mg/kg) 1 hr after haloperidol (1 mg/kg) significantly reduced the time that mice spent immobile during the bar test as compared to haloperidol alone (Figure 7A) . The behavioral effect of co-administered haloperidol, and VU0255035 was mirrored by the cellular response of D2R 
DISCUSSION
ChIs are critical elements in the control of striatal circuits (Cachope et al., 2012; Ding et al., 2010; Thorn and Graybiel, 2010; Threlfell et al., 2012; Witten et al., 2010) . ChI-D2RKO mice represent the first mouse model where D2Rs have been specifically and selectively removed from ChIs, thereby providing an excellent system to study the impact of DA signaling on these neurons.
It is known that ACh activation of nicotinic receptors on DA neurons results in a high probability of initial DA release, but limits subsequent release by high-frequency stimulation (Patel et al., 2012; Zhang and Sulzer, 2004) . Our CV analyses show that loss of D2R on ChIs impairs this finely regulated mechanism. Furthermore, the inhibition of DA overflow by quinpirole, which is completely abolished in the constitutive D2R À/À mouse (Baik et al., 1995; Rouge-Pont et al., 2002) , is partly preserved in ChI-D2RKO as well as in all conditional D2R mutants examined so far (Anzalone et al., 2012) . Thus, the control of DA release depends on D2R activation on DA neurons themselves, but also on MSNs and ChIs. ChIs are tonically active and pause in coincidence with DA bursts (Goldberg and Reynolds, 2011; Morris et al., 2004) , suggesting that DA receptor signaling contributes to the pausing (Aosaki et al., 2010; Apicella, 2002; Schulz and Reynolds, 2013; Straub et al., 2014) . We demonstrate that absence of D2R in ChIs reduces the in vitro pause of these neurons, consistent with the idea that D2R on ChIs themselves play a critical role in mediating the pause.
An additional implication that emanates from our results relates to the locomotor phenotype. Indeed, ACh signaling in the striatum is known to regulate locomotion through activation of muscarinic and nicotinic receptors located on striatal neurons and afferent fibers (Patel et al., 2012) . We demonstrate that loss of D2R signaling on ChIs does not alter baseline movement parameters. Conversely, loss of D2R signaling in ChIs significantly affects motor behavior after challenges with DA agonists or antagonists. Interestingly, behavioral responses to both D1-like (SKF81297) and D2-like (quinpirole) agonists differed between WT and ChI-D2RKO mice. Thus, our findings implicate that ChI-mediated responses gate motor activity through modulation of DA signaling.
A most unexpected finding of this study is that haloperidol, a D2R antagonist and typical antipsychotic, no longer induces catalepsy in ChI-D2RKO mice. Catalepsy in rodents is a model of the extrapyramidal syndrome and of parkinsonisms that follow antipsychotic therapies (Eskow Jaunarajs et al., 2015; Seeman, 2010) . The selective, cell-specific D2R ablation in ChIs allowed us to reveal the neuronal mechanisms underlying haloperidolinduced effects. We demonstrate that the motor-reducing effect of haloperidol is intact in ChI-D2RKO mice because dependent on blockade of D2Rs on MSNs. Surprisingly, we show that catalepsy is abolished in ChI-D2RKO mice. These results indicate that the side effects of typical antipsychotics depend on blockade of D2Rs on ChIs. The extensive expression pattern of D2Rs on multiple striatal neurons and afferent fibers has previously prevented the identification of this mechanism.
In the absence of D2Rs Figure 5 ). Thus, the catalepsy evoked by haloperidol in WT mice appears to be caused by the acute blockade of D2R not only on MSNs but also on ChIs, causing larger release of ACh and subsequent increase in ACh-mediated signaling in D2R + MSNs.
Results presented here suggest that the reduced side effects of the atypical antipsychotic clozapine and related compounds likely depend on their affinity for muscarinic receptors (Michal et al., 1999; Seeman, 2014; Sur et al., 2003; Zeng et al., 1997) . The development of novel antipsychotics targeting D2Rs or the use of existing ones together with modulators of muscarinic receptors (Kruse et al., 2014) might be fruitful pharmacological strategies that could improve antipsychotic therapies.
The present study provides the first direct evidence for the key role of D2R on ChIs in conferring normal striatal functions. It also shows that DA and ACh act in concert to orchestrate finely tuned movements through a feed-forward mechanism involving DA and ChIs. This bidirectional mechanism has a strong impact on the MSNs, the major output neurons of the striatum and consequently on movements.
EXPERIMENTAL PROCEDURES Animals
ChI-D2RKO mice were generated by breeding D2R flox-flox mice (Anzalone et al., 2012) with Tg(ChAT-CRE)24Gsat mice (MMRRC, UC Davis) (Gong et al., 2007; Gong et al., 2003 ) (see Supplemental Information). Age matched (8-to 12-week-old) male mice were used for experiments. Protocols were approved by the Institutional Animal Care and Use Committee in accordance to NIH guidelines.
FACS and qPCR
ChIs were sorted (FACSAriaII/FACSDiva) from striatal cells of ChI-D2RKO and WT mice using ChAT antibodies and RNAs were extracted, retrotranscribed, and subjected to RT-qPCR using D2R, and GAPDH primers (see Supplemental Information).
Amperometry, and CV Experiments were performed on 250 mm slices (Schmitz et al., 2002) with some modifications (see Supplemental Information).
Electrophysiological Characterization of ChIs
Recordings on coronal brain slices were made in either the cell-attached or whole-cell current clamp mode to measure spontaneous firing rate and intrinsic excitability, respectively. Pause-response experiments were performed in both modes. The pause response was measured as either the ratio of the first ISI following stimulation versus the average ISI during the baseline period (Ding et al., 2010 ) (''ISI ratio''), or as the actual pause (ISI between the last action potential during the stimulation period and the next action potential) minus the expected pause (the average ISI in the baseline period) (see Supplemental Information).
Behavioral Analyses
Locomotor activity in NHC was recorded (1 hr) using a videotracking system (Videotrack, Les Ulis). Catalepsy was measured using the bar test (Usiello et al., 2000) . Pharmacological treatments were administered in NHC and motor activity recorded as indicated in figure legends; all compounds were from Sigma (see Supplemental Information). 
Immunofluorescence Analyses
Statistical Analyses
Data are expressed as mean ± SEM. Data were analyzed by two-way ANOVA followed by either Bonferroni's post hoc comparisons or Paired two-tailed Student's t test, as appropriate, using GraphPad Prism 6.00. CV experiments with multiple pulses were analyzed by two-way ANOVA with repeated-measure followed by Bonferroni's post hoc test. In Figure 1D , F test on nonlinear regression was used. Electrophysiological experiments were analyzed by Student's t test.
SUPPLEMENTAL INFORMATION
Supplemental Information includes six figures, one 
